Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis.

Lei Ren Chengshuo Wang Lin Xi Yunbo Gao Yuan Zhang Luo Zhang

Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2023)

Children and adults with HDM-induced perennial AR could achieve a sustainable post-treatment efficacy for over three years (up to 13 years) following a three-year SCIT. Patients with relatively severe nasal symptoms at baseline may benefit more from SCIT. Children who have completed an adequate course of SCIT may gain further improvement in nasal symptoms after SCIT cessation.

Keyphrases

allergic rhinitis
young adults
drug induced
chronic rhinosinusitis
sleep quality
physical activity
oxidative stress
depressive symptoms